fig6
Figure 6. Proposed mechanism of ROS1 mutation-driven immune evasion in HNC. HNC: Head and neck cancer; APCs: antigen-presenting cells; ICIs: immune checkpoint inhibitors; TMB: tumor mutational burden; TME: tumor microenvironment; TNB: tumor neoantigen burden.
